PERCUTANEOUS MANIPULATIONS OF THE BILIARY TRACT
PERCUTANEOUS MANIPULATIONS OF THE BILIARY TRACT
PERCUTANEOUS MANIPULATIONS OF THE BILIARY TRACT
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Metal Stent Outcomes<br />
• Clinical success<br />
– Serum bilirubin decreases 63-100%<br />
• Quality of survival<br />
– Solves hydration and K + loss problems<br />
– Physiological antegrade bile flow<br />
– Shortens hospitalization time<br />
• Stent patency — 58 to 93% over 3 - 12 months<br />
• Reintervention rate decreased vs plastic<br />
• Nitinol (78%) better 6 mo patency than Z-<br />
stents (30%) and tantalum (20%)<br />
– (Rossi P, JVIR, 1994)<br />
Lee KH. et al. Biliary intervention for cholangiocarcinoma.<br />
Abdominal Imaging. 29(5):581-9, 2004 Sep-Oct.<br />
PTFE COVERED STENTS<br />
FOR MALIGNANT <strong>BILIARY</strong> OBSTRUCTION<br />
• Prospective multicenter safety and efficacy<br />
trial in Europe<br />
• 42 pts -- 38 unilateral - 4 bilateral stents<br />
• Technical success 100%<br />
• 4/42 (10%) branch obstruction<br />
• 2/42 (5%) complications<br />
– Entry site bile leak (1) and hematoma (1)<br />
– Only 1 mild case of lab pancreatitis (not complication)<br />
• 8/41 (20%) 30 day mortality - none biliary<br />
• Median primary patency 138 days<br />
• 6/41 (15%) obstruction mean 106 days<br />
• 3, 6,12 mo primary patency 90%, 76%, 76%<br />
– Schoder M et al, Radiol 2002; 225:35-42<br />
COVERED VS UNCOVERED STENTS<br />
DOES CANCER TYPE MATTER?<br />
• 73 patients with cancer<br />
– Covered stents (CS) 42, Uncovered stents (US) 31<br />
• Cholangio ca 12, gb ca 22, pancreas ca 12<br />
– 6 mo patency CS US<br />
• Overall 81% 50%<br />
– Mean time of patency CS US<br />
• Cholangio ca 15 mo 28 mo<br />
• Gb ca 13 mo 3 mo<br />
• Pancreas ca 12 mo 10 mo<br />
– Kawamoto H, Hepato-gastroenterology, 2005; 52(65): 1351-6<br />
IR Management of<br />
Liver Transplant Complications<br />
• Most recipients will have a complication<br />
– Arterial<br />
• Thrombosis 6.8% (high mortality)<br />
• Steal 5.9%<br />
– Portal 1.8%<br />
– Caval